Princeton Group International, Inc.

Strategic Consulting and Organizational Change for the Biomedical Industry

Developing strategic and business growth initiatives for pharmaceutical, biotechnology, device, diagnostic, R&D, information management and healthcare provider organizations.

33 Witherspoon St., Suite 200
Princeton, New Jersey 08542 USA
Tel 609 921-9045 or 609 921-0449 - Fax 609 921-2517
Contact us


PGI's Client Summary
PGI Success Stories
Strategic Consulting
Transactional
Consulting
PGI Principals
Inquiries
Published Articles
and Press
Buck'n'Ear

PGI provides management consulting services to the healthcare industry. We assist pharmaceutical, medical device, equipment, biotechnology and diagnostic companies and other healthcare-focused companies with business strategy, development and growth and organizational change requirements. PGI has a special franchise in identifying new technology and product opportunities and engineering alliances, joint ventures and acquisition transactions with multinational enterprises. PGI is also an advisor of choice for European biomedical enterprises seeking to enter the United States market.

PGI services include

  • Strategic and transactional consulting
  • New product/business planning and development
  • Alliance/Joint venture assistance
  • Competitive intelligence
  • Venture feasibility
  • Technology development and commercialization
  • Business analysis and evaluations
  • Evaluation of licensing opportunities
  • Product planning
  • R&D commercialization and planning

PGI helps its client companies to discover and pursue new initiatives that will materially and rapidly enhance valuation and profitable revenue growth. Included in these initiatives might be acquisitions, alliances and joint ventures as well as internal organic programs of both an operational and financial nature.PGI utilizes in its work its established relationships at senior levels in the industry.

PGI has particular expertise in the healthcare systems and markets of Western Europe and has managed transaction projects in countries around the globe including East Asia, South America, Eastern Europe and Russia as well as more developed regions..

Among PGI’s past and present clients are Bristol-Myers Squibb, Baxter International, Glaxo, Johnson & Johnson, Mallinckrodt, Orion Pharmaceuticals, Scandinavian Life Sciences Venture Fund, First Ventury Fund (Germany), EGIS Pharmaceuticals, ICON Pharmaceuticals, Strata Biosciences, CADUS Pharmaceuticals, Delsys Inc., Mass General Hospital, Beth Israel Deaconess Medical Center, North Shore Health System, U.S. State Department, Vialogy Corp, International Genomics Inc., Arthur D. Little, Cambridge Health Economics Group, Atlantic Health, Universal Health Communications, David Sarnoff Research Center, Orchid Biocomputer, Ixion Biotechnology, Immuno- Designed Molecules, Creative Biomolecules, Carmel Pharma, Affimed, Pangene Corporation, Cosmos Pharmaceuticals, Biofem Inc., Neoplasia, Inc., Cyanotech Corporation and Cantab Pharmaceuticals. PGI also provides its services pro bono to the Personalized Medicine Coalition, CaPCURE Foundation (prostate cancer) and the Harvard School of Public Health.

Our goal is bottom-line success for our clients derived from creative solutions which PGI partners in the implementation and makes happen. To see some examples of such achievements click on PGI Success Stories.

Other similar stories of the success of PGI's unique approach to helping its clients achieve their most challenging aspirations can be described and the ways we may be able to do the same for you can be explained by your contacting our offices at the above location.

For all-natural hair, skin and nail products, visit our affiliated company, Xenna Corporation at

www.xenna.com